Jesus D. Anampa, MD, MS, discussed SEER database trends in chemotherapy use for older women with TBNC and explained the rationale for using breast cancer-free survival vs OS.
Jesus D. Anampa, MD, MS
Advertisement
Articles by Jesus D. Anampa, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Investigational Radioenhancer Shows Feasibility in Stage III NSCLC
2
Alpha DaRT Overcomes Anatomical Constraints in Inoperable Pancreatic Cancer
3
101 Patient-Reported Outcomes (PROs) in Patients With ER+, HER2- Advanced Breast Cancer (ABC) Treated with Imlunestrant, Investigator’s Choice Standard Endocrine Therapy, or Imlunestrant+Abemaciclib: Results From the Phase III EMBER-3 Trial
4
Fianlimab Combo Does Not Significantly Improve PFS in Advanced Melanoma
5